Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden · Delayed Price · Currency is SEK 7.40
+0.10 (1.37%)
Apr 10, 2026, 5:07 PM CET
-69.89% (1Y)
| Market Cap | 150.42M -53.7% |
| Revenue (ttm) | 152.35M -23.3% |
| Net Income | 127.24M |
| EPS | 7.74 |
| Shares Out | 20.61M |
| PE Ratio | 1.18 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 26,123 |
| Average Volume | 37,448 |
| Open | 7.42 |
| Previous Close | 7.30 |
| Day's Range | 7.14 - 7.44 |
| 52-Week Range | 5.42 - 38.10 |
| Beta | 0.52 |
| RSI | 60.91 |
| Earnings Date | Mar 31, 2026 |